Crystallographic fragment screening against SARS-CoV-2 Nsp1 using the F2X-Entry Screen and a newly developed fragment library.
Lennartz, F., Wollenhaupt, J., Oelker, M., Froeling, P., Mueller, U., Deckers, A., Grathwol, C., Braese, S., Jung, N., Weiss, M.S.To be published.